Fructan Improves Survival and Function of Cryopreserved Rat Islets

Area of Science:

• Biomedical Science
• Regenerative Medicine
• Diabetes Research

Background:

• Cryopreservation of pancreatic islets is crucial for transplantation but often reduces viability and function.
• Current freezing methods for pancreatic tissue lack optimal efficacy.
• Islet transplantation is a key treatment for type 1 diabetes.

Purpose of the Study:

• To evaluate the efficacy of fructan as a cryoprotective agent for pancreatic islets.
• To assess the impact of fructan on islet survival, insulin secretion, and in vivo function post-cryopreservation.
• To compare fructan's performance against dimethyl sulfoxide (DMSO) in islet cryopreservation.

Main Methods:

• Rat pancreatic islets were cryopreserved using phosphate-buffered saline (PBS) with varying concentrations of fructan and/or DMSO.
• Islet survival rates were monitored over time.
• In vitro insulin secretion assays were performed.
• In vivo function was assessed via transplantation into diabetic rats, followed by histological and immunohistochemical analysis.

Main Results:

• Fructan significantly enhanced islet survival rates, with 30% fructan achieving over 90% survival at day 3.
• Islets preserved with fructan demonstrated significantly higher insulin secretion compared to DMSO-preserved islets.
• Histological analysis showed better structural integrity of islets preserved with fructan versus DMSO.
• Transplantation of fructan-preserved islets restored normal blood glucose levels in diabetic rats.

Conclusions:

• Fructan is a highly effective cryoprotective agent for pancreatic islets.
• Fructan-based cryopreservation improves islet viability and function, offering a promising alternative for diabetes treatment.
• This method holds potential for advancing islet transplantation therapies.